YUE JIANG: Open Payments
NPI 1841826369 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,561 in 49 payments from 9 companies in 2025. Trend: 2023 $843 · 2024 $5,589 · 2025 $1,561
Food & beverage: $1,366Education: $195
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 31 | $724 |
| Astellas Pharma US Inc | 7 | $272 |
| Janssen Biotech, Inc. | 4 | $233 |
| PFIZER INC. | 2 | $139 |
| Astellas Pharma Global Development | 1 | $104 |
| TOLMAR, INC. | 1 | $27 |
| pharmaand GmbH | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Eisai Inc. | 1 | $15 |
Products named: CABOMETYX, RYBREVANT, Padcev, Xtandi, ERLEADA, ELIGARD, Rubraca, Xofigo.
Industry payments across TX — which companies pay providers there.
